1 active trials 1 recruiting 1 disease areas
| Phase 4 | 1 |
| NCT ID | Title | Condition | Status | Updated |
|---|---|---|---|---|
| Phase 4 | ||||
| NCT06550453 | Safety and Efficacy of Pembrolizumab in Combination with Bevacizumab + CapeOX in the… | Locally Advanced Colorectal Cancer | Recruiting | 2024-11-12 |